Profile
F.
Allan Gordon worked as the Chief Executive Officer at Nile Therapeutics, Inc. and as the Medical Director-Scandinavia at Bristol Myers Squibb Co. He also held the position of Senior Director-Clinical Research at Scios, Inc. and Vice President-Clinical at XOMA Corp.
He was the Senior Vice President-Clinical Development at Resverlogix Corp.
for six years.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Dr. Gordon earned a doctorate degree from Karolinska Institutet.
Former positions of F. Allan Gordon
| Companies | Position | End |
|---|---|---|
| XOMA CORPORATION | Chief Tech/Sci/R&D Officer | 31/07/2017 |
| RESVERLOGIX CORP. | Chief Tech/Sci/R&D Officer | 31/12/2013 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | 31/12/2006 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Karolinska Institutet | Corporate Officer/Principal | - |
Training of F. Allan Gordon
| Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| XOMA CORPORATION | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
| Nile Therapeutics, Inc. /Old/ | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
- Stock Market
- Insiders
- F. Allan Gordon
